HY-140828-100mg
|
MedChemexpress LLC
|
m-PEG4-azide [CAS 606130-90-9]
|
|
Cancer-programmed cell death
|
|
HY-140828-50mg
|
MedChemexpress LLC
|
m-PEG4-azide [CAS 606130-90-9]
|
|
Cancer-programmed cell death
|
|
HY-130161-100mg
|
MedChemexpress LLC
|
m-PEG4-Br [CAS 110429-45-3]
|
|
Cancer-programmed cell death
|
|
HY-130161-500mg
|
MedChemexpress LLC
|
m-PEG4-Br [CAS 110429-45-3]
|
|
Cancer-programmed cell death
|
|
HY-141404-100mg
|
MedChemexpress LLC
|
m-PEG4-CH2-methyl ester [CAS 1920109-55-2]
|
|
Cancer-programmed cell death
|
|
HY-141404-50mg
|
MedChemexpress LLC
|
m-PEG4-CH2-methyl ester [CAS 1920109-55-2]
|
|
Cancer-programmed cell death
|
|
HY-115374-100mg
|
MedChemexpress LLC
|
m-PEG6-azide [CAS 1043884-49-6]
|
|
COVID-19-immunoregulation
|
|
HY-115374-250mg
|
MedChemexpress LLC
|
m-PEG6-azide [CAS 1043884-49-6]
|
|
COVID-19-immunoregulation
|
|
HY-115374-50mg
|
MedChemexpress LLC
|
m-PEG6-azide [CAS 1043884-49-6]
|
|
COVID-19-immunoregulation
|
|
HY-135932-100mg
|
MedChemexpress LLC
|
m-PEG8-O-alkyne [CAS 880081-81-2]
|
|
Cancer-programmed cell death
|
|
HY-135932-25mg
|
MedChemexpress LLC
|
m-PEG8-O-alkyne [CAS 880081-81-2]
|
|
Cancer-programmed cell death
|
|